2 July 2024 - PHARMAC is making more treatment options available for people with multiple myeloma and other blood disorders.
“From 1 August, we’re widening access to lenalidomide and we’re also funding pomalidomide for the first time, so people can live well and spend more time with their friends and whānau,” says Geraldine MacGibbon, Pharmac’s Director Pharmaceuticals.